Pacific Biosciences Of California (PACB) Cash & Current Investments (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Cash & Current Investments of $276.0 million for Q1 2026, down 19.57% year-over-year from $343.1 million in Q1 2025, and up 333.04% quarter-over-quarter from $63.7 million in Q4 2025.
Pacific Biosciences Of California (PACB) Cash & Current Investments (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $276.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 19.57% year-over-year to $276.0 million; the TTM figure through Mar 2026 stood at $276.0 million (down 19.57% YoY), while the FY2025 annual figure was $63.7 million, up 2088.43% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $276.0 million, up from $63.7 million in the prior quarter.
- The five-year high for Cash & Current Investments was $874.9 million in Q1 2023, with the low at $2.9 million in Q4 2024.
- The 5-year median for Cash & Current Investments is $343.1 million (2025), against an average of $353.8 million.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments slumped 99.33% in 2023, then surged 13551.22% in 2024.
- Pacific Biosciences Of California's Cash & Current Investments stood at $450.5 million in 2022, then plunged by 99.33% to $3.0 million in 2023, then dropped by 3.64% to $2.9 million in 2024, then surged by 2088.43% to $63.7 million in 2025, then surged by 333.04% to $276.0 million in 2026.
- Business Quant data shows PACB's Cash & Current Investments at $276.0 million in Q1 2026, $63.7 million in Q4 2025, and $244.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | 236.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 236.87 Mn |
| Mar 31, 2026 | 275.96 Mn |
| Dec 31, 2025 | 63.73 Mn |
| Sep 30, 2025 | 244.02 Mn |
| Jun 30, 2025 | 314.74 Mn |
| Mar 31, 2025 | 343.11 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 395.39 Mn |
| Jun 30, 2024 | 412.54 Mn |
| Mar 31, 2024 | 561.91 Mn |
| Dec 31, 2023 | 3.02 Mn |
| Sep 30, 2023 | 384.86 Mn |
| Jun 30, 2023 | 3.02 Mn |
| Mar 31, 2023 | 874.89 Mn |
| Dec 31, 2022 | 450.45 Mn |
| Sep 30, 2022 | 834.34 Mn |
| Jun 30, 2022 | 310.75 Mn |
| Mar 31, 2022 | 539.68 Mn |
| Dec 31, 2021 | 5.59 Mn |
| Jun 30, 2021 | 3.60 Mn |